Iranian patients co-infected with COVID-19 and mucormycosis: the most common predisposing factor, clinical outcomes, laboratory markers and diagnosis, and drug therapies

References

• Mirzadeh M, Khedmat L. Pregnant women in the exposure to COVID-19 infection outbreak: the unseen risk factors and preventive healthcare patterns. J Matern-Fetal Neonatal Med. 2022;5(7):1377–1378.
   PubMed Web of Science ®Google Scholar
• Diesel J, Sterrett N, Dasgupta S, et al. COVID-19 vaccination coverage among adults—United States, December 14, 2020–May 22, 2021. Morb Mortal Wkly Rep. 2021;70(25):922–927.
   Google Scholar
• Hashemifesharaki R, Gharibzahedi SMT. Future nutrient-dense diets rich in vitamin D: a new insight toward the reduction of adverse impacts of viral infections similar to COVID-19. Nutrire. 2020;45(2):19.
   Google Scholar
• Aghdam MH, Hosseinzadeh R, Motallebizadeh B, et al. Pathophysiology of COVID-19 infection: what is the novel coronavirus (SARS-CoV-2) doing to body? A comprehensive systematic review. Rev Med Microbiol. 2021;32(3):135–148.
   Web of Science ®Google Scholar
• Khedmat L. New coronavirus (2019-nCoV): an insight toward preventive actions and natural medicine. Int J Travel Med Glob Health. 2020;8(1):44–45.
   Google Scholar
• Khubber S, Hashemifesharaki R, Mohammadi M, et al. Garlic (allium sativum L.): a potential unique therapeutic food rich in organosulfur and flavonoid compounds to fight with COVID-19. Nutr J. 2020;19(1):124.
   PubMed Web of Science ®Google Scholar
• Zaki N, Alashwal H, Ibrahim S. Association of hypertension, diabetes, stroke, cancer, kidney disease, and high-cholesterol with COVID-19 disease severity and fatality: a systematic review. Diabetes Metab Syndr. 2020;14(5):1133–1142.
   PubMed Web of Science ®Google Scholar
• Molaei H, Khedmat L, Nemati E, et al. Iranian kidney transplant recipients with COVID‐19 infection: clinical outcomes and cytomegalovirus coinfection. Transpl Infect Dis. 2020;23(1):e13455.
   PubMedGoogle Scholar
• van Arkel AL, Rijpstra TA, Belderbos HN, et al. COVID-19-associated pulmonary Aspergillosis. Am J Respir Crit Care Med. 2020;202(1):132–135.
   PubMed Web of Science ®Google Scholar
• Al-Hatmi AM, Mohsin J, Al-Huraizi A, et al. COVID-19 associated invasive candidiasis. J Infect. 2021;82(2):e45–e46.
   PubMed Web of Science ®Google Scholar
• Páramo-Zunzunegui J, Ortega-Fernández I, Calvo-Espino P, et al. Severe Clostridium difficile colitis as potential late complication associated with COVID-19. Ann R Coll Surg Engl. 2020;102(7):e176–e179.
   PubMed Web of Science ®Google Scholar
• Palazzolo C, Maffongelli G, D’Abramo A, et al. Legionella pneumonia: increased risk after COVID-19 lockdown? Italy, May to June 2020. Euro Surveill. 2020;25(30):2001372.
   Google Scholar
• Menon AA, Berg DD, Brea EJ, et al. A case of COVID-19 and Pneumocystis jirovecii Coinfection. Am J Respir Crit Care Med. 2020;202(1):136–138.
   PubMed Web of Science ®Google Scholar
• Werthman-Ehrenreich A. Mucormycosis with orbital compartment syndrome in a patient with COVID-19. Am J Emerg Med. 2021;42:264.e5–264.e8.
   PubMed Web of Science ®Google Scholar
• Reid G, Lynch JP, III Fishbein MC, et al. Mucormycosis. Semin Respir Crit Care Med. 2020;41(1):99–114.
   PubMed Web of Science ®Google Scholar
• Chamilos G, Lewis RE, Kontoyiannis DP. Delaying amphotericin B-based frontline therapy significantly increases mortality among patients with hematologic malignancy who have zygomycosis. Clin Infect Dis. 2008;47(4):503–509.
   PubMed Web of Science ®Google Scholar
• Jeong W, Keighley C, Wolfe R, et al. The epidemiology and clinical manifestations of mucormycosis: a systematic review and meta-analysis of case reports. Clin Microbiol Infect. 2019;25(1):26–34.
   PubMed Web of Science ®Google Scholar
• Vaezi A, Moazeni M, Rahimi MT, et al. Mucormycosis in Iran: a systematic review. Mycoses. 2016;59(7):402–415.
   PubMed Web of Science ®Google Scholar
• Pagano L, Ricci P, Tonso A, et al. GIMEMA infection program. Mucormycosis in patients with haematological malignancies: a retrospective clinical study of 37 cases. Br J Haematol. 1997;99:331–336.
   PubMed Web of Science ®Google Scholar
• Pagano L, Offidani M, Fianchi L, GIMEMA (Gruppo Italiano Malattie EMatologiche dell'Adulto) Infection Program, et al. Mucormycosis in hematologic patients. Haematologica. 2004;89(2):207–214.
   PubMed Web of Science ®Google Scholar
• Al‐Sarraj S, Troakes C, Hanley B, et al. Invited review: the spectrum of neuropathology in COVID‐19. Neuropathol Appl Neurobiol. 2021;47(1):3–16.
   PubMed Web of Science ®Google Scholar
• Song G, Liang G, Liu W. Fungal co-infections associated with global COVID-19 pandemic: a clinical and diagnostic perspective from China. Mycopathologia. 2020;185(4):599–606.
   PubMed Web of Science ®Google Scholar
• Cornely OA, Alastruey-Izquierdo A, Arenz D, et al. Global guideline for the diagnosis and management of mucormycosis: an initiative of the European Confederation of Medical Mycology in cooperation with the mycoses study group education and research consortium. Lancet Infect Dis. 2019;19(12):e405–21.
   PubMed Web of Science ®Google Scholar
• Mehta S, Pandey A. Rhino-orbital mucormycosis associated with COVID-19. Cureus. 2020;12(9):e10726.
   PubMed Web of Science ®Google Scholar
• Veisi A, Bagheri A, Eshaghi M, et al. Rhino-orbital mucormycosis during steroid therapy in COVID-19 patients: a case report. Eur J Ophthalmol. 2021. DOI:https://doi.org/10.1177/11206721211009450
   Google Scholar
• Maini A, Tomar G, Khanna D, et al. Sino-orbital mucormycosis in a COVID-19 patient: a case report. Int J Surg Case Rep. 2021;82:105957.
   PubMed Web of Science ®Google Scholar
• Mekonnen ZK, Ashraf DC, Jankowski T, et al. Acute invasive rhino-orbital mucormycosis in a patient with COVID-19-associated acute respiratory distress syndrome. Ophthalmic Plast Reconstr Surg. 2021;37(2):e40–e80.
   PubMed Web of Science ®Google Scholar
• Garg D, Muthu V, Sehgal IS, et al. Coronavirus disease (Covid-19) associated mucormycosis (CAM): case report and systematic review of literature. Mycopathologia. 2021;186(2):289–298.
   PubMed Web of Science ®Google Scholar
• Zurl C, Hoenigl M, Schulz E, et al. Autopsy proven pulmonary mucormycosis due to Rhizopus microsporus in a critically ill COVID-19 patient with underlying hematological malignancy. J Fungi. 2021;7:88.
   Web of Science ®Google Scholar
• Waizel-Haiat S, Guerrero-Paz JA, Sanchez-Hurtado L, et al. A case of fatal rhino-orbital mucormycosis associated with new onset diabetic ketoacidosis and COVID-19. Cureus. 2021;13(2):e13163.
   PubMed Web of Science ®Google Scholar
• Alekseyev K, Didenko L, Chaudhry B. Rhinocerebral mucormycosis and COVID-19 pneumonia. J Med Cases. 2021;12(3):85–89.
   PubMedGoogle Scholar
• Johnson AK, Ghazarian Z, Cendrowski KD, et al. Pulmonary aspergillosis and mucormycosis in a patient with COVID-19. Med Mycol Case Rep. 2021;32:64–67.
   PubMed Web of Science ®Google Scholar
• Hussain S, Baxi H, Riad A, et al. COVID-19-associated mucormycosis (CAM): an updated evidence mapping. Int J Environ Res Public Health. 2021;18(19):10340.
   PubMed Web of Science ®Google Scholar
• Riad A, Shabaan AA, Issa J, et al. COVID-19-associated mucormycosis (CAM): case-series and global analysis of mortality risk factors. J Fungi. 2021;7(10):837.
   Web of Science ®Google Scholar
• Dilek A, Ozaras R, Ozkaya S, et al. COVID-19-associated mucormycosis: case report and systematic review. Travel Med Infect Dis. 2021;44:102148.
   PubMed Web of Science ®Google Scholar
• Mishra N, Mutya VS, Thomas A, et al. A case series of invasive mucormycosis in patients with COVID-19 infection. Int J Otorhinolaryngol Head Neck Surg. 2021;7(5):867–870.
   Google Scholar
• Buil JB, van Zanten AR, Bentvelsen RG, et al. Case series of four secondary mucormycosis infections in COVID-19 patients, The Netherlands. December 2020 to May 2021. Eurosurveillance. 2021;26(23):2100510.
   Web of Science ®Google Scholar
• Hanley B, Naresh KN, Roufosse C, et al. Histopathological findings and viral tropism in UK patients with severe fatal COVID-19: a post-mortem study. Lancet Microbe. 2020;1(6):e245-53–e253.
   Google Scholar
• Monte Junior ESD, Santos M, Ribeiro IB, et al. Rare and fatal gastrointestinal mucormycosis (zygomycosis) in a COVID-19 patient: a case report. Clin Endosc. 2020;53:746–749.
   PubMed Web of Science ®Google Scholar
• Pasero D, Sanna S, Liperi C, et al. A challenging complication following SARS-CoV-2 infection: a case of pulmonary mucormycosis. Infection. 2021;49(5):1055–1060.
   PubMed Web of Science ®Google Scholar
• Remy KE, Mazer M, Striker DA, et al. Severe immunosuppression and not a cytokine storm characterizes COVID-19 infections. JCI Insight. 2020;5(17):e140329.
   PubMed Web of Science ®Google Scholar
• Rammaert B, Lanternier F, Poiree S, et al. Diabetes and mucormycosis: a complex interplay. Diabetes Metab. 2012;38(3):193–204.
   PubMed Web of Science ®Google Scholar
• White L, Dhillon R, Cordey A, et al. A national strategy to diagnose COVID-19 associated invasive fungal disease in the ICU. Clin Infect Dis. 2021;73(7):e1634–e1644.
   PubMed Web of Science ®Google Scholar
• Kimmig LM, Wu D, Gold M, et al. IL-6 inhibition in critically ill COVID-19 patients is associated with increased secondary infections. Front Med. 2020;7:583897.
   PubMed Web of Science ®Google Scholar